Intel Corporation faces challenges with market share & revenue, but their turnaround plan shows promise. Click for my review ...
On behalf of the Board of Directors, management, and employees of Outlook Therapeutics, I want to extend my deepest gratitude ...
Welcome, and thank you for standing by. [Operator Instructions] Today’s conference is being recorded. If you have any ...
Norway's eurosceptic Centre Party quit the government on Thursday in a dispute over the adoption of European Union energy ...
A leaked EU competitiveness strategy is prompting fears that Brussels intends to undermine the independence of the European ...
Viren Merchant’s visionary leadership, coupled with Radhika Merchant’s emerging success, ensures that the family’s ...
Analyst Michael Sison from Wells Fargo maintained a Buy rating on Ashland (ASH – Research Report) and keeping the price target at $90.00.Invest ...
Ruling parties face hurdles in National Assembly despite having a near 2/3 majority in House of Representatives.
Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...
Welcome and thank you for standing by. (Operator Instructions) Today's conference is being recorded. If you have any objections, you may disconnect at this time. Now I will turn the meeting over to ...